US 8709995
Method for eliciting an immune response to human telomerase reverse transcriptase
granted A61KA61K2039/55505A61K2039/55511
Quick answer
US patent 8709995 (Method for eliciting an immune response to human telomerase reverse transcriptase) held by The Regents of the University of Colorado expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado
- Grant date
- Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K2039/55505, A61K2039/55511, A61K2039/55516, A61K2039/55544